11/23
Allergic Rhinitis ? Pipeline Review, H1 2013Respiratory◇【医療 介護 福祉】【RCP】
List of TablesNumber of Products Under Development for Allergic Rhinitis, H1 2013 15Products under Development for Allergic Rhinitis ? Comparative Analysis, H1 2013 16Number of Products under Development by Companies, H1 2013 18Number of Products under Development by Companies, H1 2013 (Contd..1) 19Number of Products under Development by Companies, H1 2013 (Contd..2) 20Number of Products under Investigation by Universities/Institutes, H1 2013 21Comparative Analysis by Late Stage Development, H1 2013 22Comparative Analysis by Mid Clinical Stage Development, H1 2013 23Comparative Analysis by Early Clinical Stage Development, H1 2013 24Comparative Analysis by Discovery and Pre-Clinical Stage Development, H1 2013 25Products under Development by Companies, H1 2013 26Products under Development by Companies, H1 2013 (Contd..1) 27Products under Development by Companies, H1 2013 (Contd..2) 28Products under Development by Companies, H1 2013 (Contd..3) 29Products under Development by Companies, H1 2013 (Contd..4) 30Products under Investigation by Universities/Institutes, H1 2013 31Johnson & Johnson, H1 2013 32Boehringer Ingelheim GmbH, H1 2013 33Bausch & Lomb Incorporated, H1 2013 34Shionogi & Co., Ltd., H1 2013 35Sanofi-Aventis, H1 2013 36GlaxoSmithKline plc, H1 2013 37Genentech, Inc., H1 2013 38Nektar Therapeutics, H1 2013 39MedImmune LLC, H1 2013 40Merck & Co., Inc., H1 2013 41Dainippon Sumitomo Pharma Co., Ltd., H1 2013 42Novartis AG, H1 2013 43ALK-Abello A/S, H1 2013 44Meda AB, H1 2013 45Mitsubishi Tanabe Pharma Corporation, H1 2013 46Ono Pharmaceutical Co., Ltd., H1 2013 47Pfizer Inc., H1 2013 48Teijin Limited, H1 2013 49Teva Pharmaceutical Industries Limited, H1 2013 50Zeria Pharmaceutical Co Ltd, H1 2013 51Sun Pharmaceutical Industries Limited, H1 2013 52Capnia, Inc., H1 2013 53FAES Farma SA, H1 2013 54Nuvo Research Inc., H1 2013 55Array BioPharma Inc., H1 2013 56Stallergenes S.A., H1 2013 57Torii Pharmaceutical Co., Ltd., H1 2013 58GenMont Biotech Inc., H1 2013 59Allergopharma Joachim Ganzer KG, H1 2013 60Palau Pharma S.A, H1 2013 61Respiratorius AB, H1 2013 62Oxagen Limited, H1 2013 63Axikin Pharmaceuticals, Inc., H1 2013 64Vantia Therapeutics, H1 2013 65VentiRx Pharmaceuticals, Inc., H1 2013 66Adamis Pharmaceuticals Corporation, H1 2013 67Laboratorios LETI S.L., H1 2013 68Morria Biopharmaceuticals Plc, H1 2013 69Viromed Co., Ltd., H1 2013 70Afexa Life Sciences Inc., H1 2013 71Lipocine Inc., H1 2013 72Indigene Pharmaceuticals, Inc., H1 2013 73Eurofarma, H1 2013 74Assessment by Monotherapy Products, H1 2013 75Assessment by Combination Products, H1 2013 76Assessment by Stage and Route of Administration, H1 2013 78Assessment by Stage and Molecule Type, H1 2013 80Allergic Rhinitis Therapeutics ? Drug Profile Updates 172Allergic Rhinitis Therapeutics ? Discontinued Products 188Allergic Rhinitis Therapeutics ? Discontinued Products (Contd..1) 189Allergic Rhinitis Therapeutics ? Dormant Products 190Allergic Rhinitis Therapeutics ? Dormant Products (Contd..1) 191Allergic Rhinitis Therapeutics ? Dormant Products (Contd..2) 192Allergic Rhinitis Therapeutics ? Dormant Products (Contd..3) 193Allergic Rhinitis Therapeutics ? Dormant Products (Contd..4) 194List of FiguresNumber of Products under Development for Allergic Rhinitis, H1 2013 15Products under Development for Allergic Rhinitis ? Comparative Analysis, H1 2013 16Products under Development by Companies, H1 2013 17Products under Investigation by Universities/Institutes, H1 2013 21Late Stage Products, H1 2013 22Mid Clinical Stage Products, H1 2013 23Early Clinical Stage Products, H1 2013 24Discovery and Pre-Clinical Stage Products, H1 2013 25Assessment by Monotherapy Products, H1 2013 75Assessment by Combination Products, H1 2013 76Assessment by Route of Administration, H1 2013 77Assessment by Stage and Route of Administration, H1 2013 78Assessment by Molecule Type, H1 2013 79Assessment by Stage and Molecule Type, H1 2013 80"本商品は、シングルライセンスとなります。複数の拠点での利用をご検討の際には、直接お問い合わせください。また、本サイトで掲載している商品以外にも多数のレポートを取りそろえておりますので、もしご要望などあれば、お気軽にお問い合わせください。"■本商品について本商品は、お客様の問題解決のためのヒントとしてご利用ください。本商品の記載内容は、お客様固有の問題に対し、適切であるかどうか、また、正確であるかどうかは十分検証されていません。結果について、いかなる保証も責任も負いかねますので、あらかじめご了承ください。他のメディア等に無断で転載する事は禁止となります。■著作権・再配布について本シリーズで提供している商品は、提供されるすべての著作物について、その著作権は発行元にあります。非営利目的の個人利用、営利目的の利用問わず、ご購入者様のマーケティング以外の利用については禁止させていただきます。また、掲載内容の外部サイトなどへの転載および再配布を禁止しています。 上記を守られない場合、著作権違法行為になります。つまり罪です。場合によっては、法的な措置に出ることもございますので、ご注意ください。Allergic Rhinitis Therapeutic Products under Development, Key Players in Allergic Rhinitis Therapeutics, Allergic Rhinitis Pipeline Overview, Allergic Rhinitis Pipeline, Allergic Rhinitis Pipeline Assessmentレポートタイトル：Allergic Rhinitis ? Pipeline Review, H1 2013国：Global市場：Pharmaceuticals and Healthcare発行元：Global Markets Direct情報：年度：2013発行日：28-Feb-2013ページ：2050
Allergic Rhinitis ? Pipeline Review, H1 2013
「キャッチコピー引用」
2013年11月23日 11時 土曜日feat. D.O Normal 続き＞＞